CLDN3 and cancer: The overexpression of CLDN3 can lead to a decrease in or even loss of cell–cell adhesion, resulting in the promotion of epithelial–mesenchymal transition (EMT), which is implicated in the pathophysiology of numerous types of cancers [35,36].